Molina Healthcare, Inc (NYSE:MOH) shares have been under pressure following a string of analyst reviews and sector headwinds, pushing the stock toward its 52-week low. Investors are weighing mixed signals as price targets adjust and earnings forecasts shift.
Positive Sentiment:
Mizuho lowered its price target on MOH from $400 to $330 but maintained an “outperform” rating, implying roughly 49% upside from current levels.
Mizuho cuts price target
Neutral Sentiment:
JP Morgan trimmed its price target to $333 from $350 but left MOH at a Hold rating, reflecting cautious outlook without outright bearishness.
JP Morgan adjusts forecast
Neutral Sentiment:
Molina Healthcare reported preliminary Q2 2025 results and provided updated full-year EPS guidance, with details to be confirmed in the official release.
Q2 preliminary results
Neutral Sentiment:
Around July 11, equities analysts published a range of FY2025 earnings forecasts for MOH, highlighting uncertainty in Medicaid managed-care margins.
FY2025 earnings predictions
Negative Sentiment:
Cantor Fitzgerald cut its FY2025 EPS estimate for MOH to $22.00 from $24.65, below the consensus of $24.40, reflecting concerns over profitability.
Cantor Fitzgerald cuts EPS
Negative Sentiment:
Morgan Stanley downgraded MOH from “Overweight” to “Equal Weight” and slashed its target to $266 from $364, signaling less confidence in near-term upside.
Morgan Stanley downgrade
Negative Sentiment:
MOH stock sank to a 52-week low amid the earnings estimate revisions and broader sector pressures on managed care providers.
Stock hits 52-week low
Negative Sentiment:
Analysts warn MOH faces near-term challenges in its Medicaid plans and may face further downgrades absent clearer margin improvements.
Analyst warns of downgrade
Posted 1+ days ago
AI Generated. May Contain Errors.